We also observed tumor cells derived from KRAS/TP53 dual mutant cancers had the highest CNV score (Figure 2E, left and middle), while tumor cells from left-sided colorectal cancers had a higher CNV score than right-sided tumors (Figure 2E, right). This evidence concerns the gene TP53 and colorectal cancer.